术中体外膜肺氧合及术后延长支持的可能性改善双肺移植生存
该单中心回顾性分析纳入2010年1月至2016年6月所有标准双肺移植,分为无ECMO组(n=116)、术中ECMO组(n=343)和术中联合术后延长ECMO组(n=123),发现术中ECMO组1年、3年、5年生存率均优于无ECMO组,术后预防性延长ECMO在肺动脉高压及移植物功能存疑受者中结局良好。
要点
- 术中ECMO与无ECMO相比改善1年、3年、5年生存率(91% vs 82%,85% vs 76%,80% vs 74%;log-rank P=.041)。
- 倾向性评分匹配后术中ECMO的生存优势仍明显。
- 术后预防性延长ECMO在肺动脉高压及移植物功能存疑受者中结局优良。
核心结论
- 术中ECMO与不使用任何体外支持的移植相比带来更优的生存。
- 术后预防性延长ECMO的概念在肺动脉高压受者及植入结束时移植物功能存疑的患者中与优良结局相关。
研究设计与样本
- 单中心回顾性分析,纳入2010年1月至2016年6月期间所有标准双肺移植。
- 患者分为三组:I组无ECMO(n=116),II组术中ECMO(n=343),III组术中及术后延长ECMO(n=123)。
- 分析不同ECMO策略对原发移植物功能、短期结局和患者生存的影响。
主要发现
- 术中ECMO组与无ECMO组相比1年、3年、5年生存率分别为91% vs 82%、85% vs 76%、80% vs 74%(log-rank P=.041)。
- 对两组队列进行倾向性评分匹配后该效应仍明显。
- 尽管III组复杂患者数量多,其结局优良,所有时间点生存率均高于无ECMO组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The value of intraoperative extracorporeal membrane oxygenation (ECMO) in lung transplantation remains controversial. In our department, ECMO has been used routinely for intraoperatively unstable patients for more than 15 years. Recently, we have extended its indication to a preemptive application in almost all cases. In addition, we prolong ECMO into the early postoperative period whenever graft function does not meet certain quality criteria or in patients with primary pulmonary hypertension. The objective of this study was to review the results of this strategy. METHODS: All standard bilateral lung transplantations performed between January 2010 and June 2016 were included in this single-center, retrospective analysis. Patients were divided into 3 groups: group I-no ECMO (n = 116), group II-intraoperative ECMO (n = 343), and group III-intraoperative and prolonged postoperative ECMO (n = 123). The impact of different ECMO strategies on primary graft function, short-term outcomes, and patient survival were analyzed. RESULTS: The use of intraoperative ECMO was associated with improved 1-, 3-, and 5-year survival compared with non-ECMO patients (91% vs 82%, 85% vs 76%, and 80% vs 74%; log-rank P = .041). This effect was still evident after propensity score matching of both cohorts. Despite the high number of complex patients in group III, outcome was excellent with higher survival rates than in the non-ECMO group at all time points. CONCLUSIONS: Intraoperative ECMO results in superior survival when compared with transplantation without any extracorporeal support. The concept of prophylactic postoperative ECMO prolongation is associated with excellent outcomes in recipients with pulmonary hypertension and in patients with questionable graft function at the end of implantation.
引用
- Hoetzenecker K, Schwarz S, Muckenhuber M, et al. Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantation. J Thorac Cardiovasc Surg. 2017. PMID: 29653665. doi:10.1016/j.jtcvs.2017.10.144
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。